Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ongoing Exposure of U.K. Infants to Vaccine Serotype Pneumococci.
Slack M, Vyse A, Madhava H, Reinert RR, Ellsbury G, Czudek C, Gessner B. Slack M, et al. Pediatr Infect Dis J. 2019 Apr;38(4):444. doi: 10.1097/INF.0000000000002184. Pediatr Infect Dis J. 2019. PMID: 30882750 No abstract available.
Burden of Invasive Pneumococcal Disease.
Slack M, Vyse A, Madhava H, Ellsbury G, Czudek C, Reinert RR, Gessner B. Slack M, et al. Clin Infect Dis. 2019 Sep 27;69(8):1465-1466. doi: 10.1093/cid/ciz190. Clin Infect Dis. 2019. PMID: 30843037 No abstract available.
Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack MPE. Vyse A, et al. Expert Rev Vaccines. 2022 Jun;21(6):871-872. doi: 10.1080/14760584.2022.2047024. Epub 2022 Mar 8. Expert Rev Vaccines. 2022. PMID: 35226814 Free article. No abstract available.
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.
Vyse A, Campling J, Czudek C, Ellsbury G, Slack M. Vyse A, et al. Among authors: slack m. Vaccine. 2020 Dec 3;38(51):8068-8070. doi: 10.1016/j.vaccine.2020.10.090. Epub 2020 Nov 12. Vaccine. 2020. PMID: 33190949 No abstract available.
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK.
Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack M. Vyse A, et al. Among authors: slack m. Expert Rev Vaccines. 2021 Oct;20(10):1311-1325. doi: 10.1080/14760584.2021.1984888. Epub 2021 Oct 19. Expert Rev Vaccines. 2021. PMID: 34550850 Free article. Review.
468 results